Skip to Main Content

Author Details

Gabriella Orlando
Azienda Ospedaliero-Universitaria, University of Modena and Reggio Emilia
1988
83
25
Sarah J Ratcliffe (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37317086A Fatal Case of <i>Pseudomonas aeruginosa</i> Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review.Microorganisms2023
37908359Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC <i>vs.</i> B/F/TAF: the DEBATE trial.Front Immunol2023
37957773Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: a matched case-control study.Antimicrob Resist Infect Control2023
37998841Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections.Antibiotics (Basel)2023
36009885Is It Possible to Eradicate Carbapenem-Resistant <i>Acinetobacter baumannii</i> (CRAB) from Endemic Hospitals?Antibiotics (Basel)2022
35740232Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015-2021).Antibiotics (Basel)2022
35892396Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature.Antibiotics (Basel)2022
33074365Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature.Infection2021
33832538Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case-control study.Antimicrob Resist Infect Control2021
34909691Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant <i>Pseudomonas aeruginosa</i> (DTR-P) infections.JAC Antimicrob Resist2021
35146362Development of post-COVID-19 cardiovascular events: an analysis of clinical features and risk factors from a single hospital retrospective study.Infez Med2021
34412693A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit.Antimicrob Resist Infect Control2021
34383784The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study.PLoS One2021
34576791Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study.Microorganisms2021
34680805Combined Resistance to Ceftolozane-Tazobactam and Ceftazidime-Avibactam in Extensively Drug-Resistant (XDR) and Multidrug-Resistant (MDR) <i>Pseudomonas aeruginosa</i>: Resistance Predictors and Impact on Clinical Outcomes Besides Implications for Antimicrobial Stewardship Programs.Antibiotics (Basel)2021
34827257Challenges to Antimicrobial Stewardship in the Countries of the Arab League: Concerns of Worsening Resistance during the COVID-19 Pandemic and Proposed Solutions.Antibiotics (Basel)2021
34162049Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients.Kidney Res Clin Pract2021
34196877Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19.Clin Exp Nephrol2021
34307725The Impact of COVID-19 on UNAIDS 90-90-90 Targets: Calls for New HIV Care Models.Open Forum Infect Dis2021
34136341Beauveria bassiana keratitis: Management of an atypical clinical presentation.Med Mycol Case Rep2021
32408565A Retrospective Whole-Genome Sequencing Analysis of Carbapenem and Colistin-Resistant <i>Klebsiella Pneumoniae</i> Nosocomial Strains Isolated during an MDR Surveillance Program.Antibiotics (Basel)2020
33180787Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia-Challenges, strengths, and opportunities in a global health emergency.PLoS One2020
32835257Tocilizumab in patients with severe COVID-19: a retrospective cohort study.Lancet Rheumatol2020
32784434Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period.Microorganisms2020
31577384Significant chronic airway abnormalities in never-smoking HIV-infected patients.HIV Med2019
30076978Antimicrobial consumption and impact of antimicrobial stewardship programmes in long-term care facilities.Clin Microbiol Infect2019
29441479Re: Lebentrau S, Gilfrich C, Vetterlein MW, Schumacher H, Spachmann PJ, Brookman-May SD, Fritsche HM, Schostak M, Wagenlehner F, Burger M, May M, MR2 study group (2017) Impact of the medical specialty on knowledge regarding multidrug-resistant organisms and strategies toward antimicrobial stewardship. Int Urol Nephrol 49:1311-1318.Int Urol Nephrol2018
27453168Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome.Dig Liver Dis2016
26268373Independent association of subclinical coronary artery disease and emphysema in HIV-infected patients.HIV Med2016
27999807Clinical and Microbiological Characteristics of Visceral Leishmaniasis Outbreak in a Northern Italian Nonendemic Area: A Retrospective Observational Study.Biomed Res Int2016
24216034Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: the Monarch randomized controlled trial.Int J STD AIDS2014
25354261The burden of image based emphysema and bronchiolitis in HIV-infected individuals on antiretroviral therapy.PLoS One2014
24750806The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection.HIV Med2014
24536088Gender differences in GH response to GHRH+ARG in lipodystrophic patients with HIV: a key role for body fat distribution.Eur J Endocrinol2014
23700409Combined use of waist and hip circumference to identify abdominally obese HIV-infected patients at increased health risk.PLoS One2013
24098086Cost of noninfectious comorbidities in patients with HIV.Clinicoecon Outcomes Res2013
23924586Randomized trial to evaluate cardiometabolic and endothelial function in patients with plasma HIV-1 RNA suppression switching to darunavir/ritonavir with or without nucleoside analogues.HIV Clin Trials2013
23975212Inverse correlation between vascular calcification and bone mineral density in human immunodeficiency virus-infected patients.Calcif Tissue Int2013
21477014Erectile dysfunction is not a mirror of endothelial dysfunction in HIV-infected patients.J Sex Med2012
22709756Parallel increase of subclinical atherosclerosis and epicardial adipose tissue in patients with HIV.Am Heart J2012
22189998GH response to GHRH plus arginine is impaired in lipoatrophic women with human immunodeficiency virus compared with controls.Eur J Endocrinol2012
22186503Long-term efficacy and safety of polyacrylamide hydrogel injection in the treatment of human immunodeficiency virus-related facial lipoatrophy: a 5-year follow-up.Plast Reconstr Surg2012
21717261High-density hyaluronic acid for the treatment of HIV-related facial lipoatrophy.Aesthetic Plast Surg2012
21643942Progression of coronary artery calcium in men affected by human immunodeficiency virus infection.Int J Cardiovasc Imaging2012
20975513Surgical correction of HIV-associated facial lipoatrophy.AIDS2011
22227046Human immunodeficiency virus is the major determinant of steatosis and hepatitis C virus of insulin resistance in virus-associated fatty liver disease.Arch Med Res2011
21998278Premature age-related comorbidities among HIV-infected persons compared with the general population.Clin Infect Dis2011
22174826Premature decline of serum total testosterone in HIV-infected men in the HAART-era.PLoS One2011
21919542Morphological and metabolic components of lipodystrophy in various nevirapine-based highly active antiretroviral therapy (HAART) regimens: a cross-sectional, observational study.Clin Drug Investig2011
21966404Hypertriglyceridemia and waist circumference predict cardiovascular risk among HIV patients: a cross-sectional study.PLoS One2011
  • 1 - 50 of 83

Recommended Authors

Padua University Hospital
Career Start Year 2016
Number of shared co-authors 3
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 1
University of Witwatersrand
Career Start Year 2000
Number of shared co-authors 1
Northwestern University Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 0
Lausanne University Hospital, University of Lausanne
Career Start Year 1999
Number of shared co-authors 0
Yale School of Public Health
Career Start Year 1999
Number of shared co-authors 0
The University of North Carolina School of Medicine
Career Start Year 1997
Number of shared co-authors 2
Johns Hopkins Bloomberg School of Public Health
Career Start Year 1993
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 1992
Number of shared co-authors 1
Hospital Universitario de Guadalajara
Career Start Year 1991
Number of shared co-authors 0
Johns Hopkins School of Medicine, Johns Hopkins University
Career Start Year 1990
Number of shared co-authors 1
David Geffen School of Medicine, University of California los angeles
Career Start Year 1989
Number of shared co-authors 2
La Paz University Hospital
Career Start Year 1988
Number of shared co-authors 4
University of Cincinnati
Career Start Year 1988
Number of shared co-authors 2
Hospital Clinico San Carlos-IdiSSC, Universidad Complutense
Career Start Year 1988
Number of shared co-authors 0
VA Connecticut Healthcare System
Career Start Year 1988
Number of shared co-authors 2
University Medical Center Utrecht
Career Start Year 1988
Number of shared co-authors 1
University of Massachusetts Medical School-Baystate
Career Start Year 1988
Number of shared co-authors 1
University of Nebraska Medical Center
Career Start Year 1987
Number of shared co-authors 1
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 5
University of Washington
Career Start Year 1984
Number of shared co-authors 1
David Geffen School of Medicine, University of California los angeles
Career Start Year 1982
Number of shared co-authors 2
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 1
Case Western Reserve University
Career Start Year 1981
Number of shared co-authors 0
University of California San Francisco
Career Start Year 1981
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1980
Number of shared co-authors 2
School of Public Health, university of california san diego
Career Start Year 1980
Number of shared co-authors 0
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Career Start Year 1979
Number of shared co-authors 2
University of Miami, Miller School of Medicine
Career Start Year 1977
Number of shared co-authors 1
Vir Biotechnology Inc.
Career Start Year 1977
Number of shared co-authors 3

Collaborators

University Hospital of Modena Policlinico, University of Modena and Reggio Emilia
Co-authored papers 65
Azienda Ospedaliero-Universitaria Policlinico of Modena
Co-authored papers 31
University of Modena and Reggio Emilia, Policlinico di Modena
Co-authored papers 10
University of Modena and Reggio Emilia
Co-authored papers 8
Co-authored papers 4
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 3
Co-authored papers 2
IRCCS-ISMETT
Co-authored papers 2
University of Virginia
Co-authored papers 1
College of Medicine, Drexel University
Co-authored papers 1
Universita della Svizzera Italiana (USI)
Co-authored papers 1
&quotMagna Graecia&quot University
Co-authored papers 1
Division of Hospital Medicine.
Co-authored papers 1
University of Pennsylvania Perelman School of Medicine
Co-authored papers 1